Skip to main content
. 2015 Dec 3;2015(12):CD002243. doi: 10.1002/14651858.CD002243.pub3
Methods Randomized controlled trial
1 centre
Participants Adults (n = 75) with sepsis and septic shock
Interventions
  • Methylprednisolone (30 mg/kg 15‐minute intravenous infusion every 6 hours for 24 hours)

  • Placebo

Outcomes PRIMARY
  • Prevention of ARDS


SECONDARY
  • Hospital mortality

Notes Study location: USA
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated randomization scheme
Allocation concealment (selection bias) Low risk Randomization list kept confidential by the pharmacist
Blinding (performance bias and detection bias) All outcomes Low risk Participants: yes
Care‐givers: yes
Data collectors: yes
Outcome assessors: yes
Data analysts: yes
Incomplete outcome data (attrition bias) All outcomes High risk 12 out of 87 randomly assigned participants were not analysed, and their follow‐up was not given
Selective reporting (reporting bias) Unclear risk No access to study protocol
Other bias Unclear risk No access to data to exclude selection bias